{"name":"Mundipharma AB","slug":"mundipharma-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Transdermal delivery system","genericName":"Transdermal delivery system","slug":"transdermal-delivery-system","indication":"Other","status":"marketed"},{"name":"Mannitol challenge test & reversibility test","genericName":"Mannitol challenge test & reversibility test","slug":"mannitol-challenge-test-reversibility-test","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Transdermal delivery system","genericName":"Transdermal delivery system","slug":"transdermal-delivery-system","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Mannitol challenge test & reversibility test","genericName":"Mannitol challenge test & reversibility test","slug":"mannitol-challenge-test-reversibility-test","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNcWo1eHdUdHpUQkJkN0xiTmdLSmhBREhGNF9uYkx5QnY2SFUweGxOY2tCZ2tEajZhU2lyaDF3VzZ6d3RoVDNPbTlwSDNZZjExSDV4NUJPSGVHVndDelZZcG51Z2pnb1lBWnBNVDlPdW5oNGMwTlA1NHFSNXFlQ2tYYkpZUWpUd0xpWnB6NmZydVEzNjFZamc?oc=5","date":"2019-07-10","type":"deal","source":"Contract Pharma","summary":"Mundipharma Acquires Rights to Orexo’s Zubsolv - Contract Pharma","headline":"Mundipharma Acquires Rights to Orexo’s Zubsolv","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}